Effect of the Specific Carbohydrate Diet on the Microbiome of a Primary Sclerosing Cholangitis and Ulcerative Colitis Patient.

about

Effect of the Specific Carbohydrate Diet on the Microbiome of a Primary Sclerosing Cholangitis and Ulcerative Colitis Patient.

Item

http://www.wikidata.org/entity/Q55036308

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@en

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@nl

type

Item

label

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@en

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@nl

prefLabel

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@en

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@nl

P1476

Effect of the Specific Carbohy ...... nd Ulcerative Colitis Patient.

@en

P2093

Alanna Dubrovsky

http://www.w3.org/2001/XMLSchema#string

P2860

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

Advances in nutritional therapy in inflammatory bowel diseases: Review

Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.

Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha.

Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.

Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.

Fusobacterium Isolates Recovered From Colonic Biopsies of Inflammatory Bowel Disease Patients in Korea.

P304

e2177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.7759/CUREUS.2177

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher L Kitts

P577

2018-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29651370

http://www.w3.org/2001/XMLSchema#string

P921

microbiome

cholangitis

P932

5890963

http://www.w3.org/2001/XMLSchema#string